Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

This Solicitation opportunity from Government of Canada was posted on December 23, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pralidoxime

Closed
W6369-26-A033Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--762-26-3-040-2307 -Tucson CMOP PROPRANOLOL -(VA-26-00068676)
National Cmop Office (36C770)

POSTED

about 18 hours ago

DEADLINE

in 7 days
NAICS: 325412
New
DIBBS
INHALER, SPACING DEVThe contract pertains to the procurement of inhaler spacing devices, identified by the National Stock Number 6515-01-538-2141, with a quantity of five units requested. The solicitation, numbered SPE2DS-26-T-146M, was issued by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on June 10, 2026, and responses were due by June 16, 2026. This is a federal procurement effort, although there is no specified type of set-aside or detailed NAICS code provided. The place of performance and detailed office address are not disclosed in the contract data, and no specific point of contact information is listed. The procurement is managed through the DLA’s bidding platform.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 325412
New
DIBBS
LORATADINE TABLETSThe contract pertains to the procurement of Loratadine tablets, identified under the National Stock Number 6505-01-524-9179, with a requested quantity of four units. It is issued by the Defense Logistics Agency within the Department of Defense as a federal solicitation with the reference number SPE2DP-26-T-3776. The solicitation was posted on June 10, 2026, and the deadline for responses is June 16, 2026. The solicitation does not specify any type of set aside or NAICS code, and details regarding the place of performance or specific office addresses are not provided. This contract opportunity is open to federal organizations, and interested parties can access further information through the official procurement website linked with the Defense Logistics Agency.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 325412
New
Federal
Radioactive Isotope Preparation and EncapsulationThe contract involves the preparation and encapsulation of radioactive calibration standards utilizing isotopes such as Cd-109, Cs-137, and Co-60. These isotopes are to be incorporated into various matrices and container types while ensuring uniform distribution and proper sealing to meet regulatory and safety requirements. The work is associated with the Environmental Protection Agency and is designated as a subcontract under the NAICS code 325412. The solicitation was posted on June 10, 2026, with a response deadline of June 16, 2026. The contract focuses on precise and compliant handling of radioactive materials to produce reliable calibration standards necessary for environmental and safety monitoring purposes. Specific location details and contact information are not provided, and interested parties are directed to the official FedConnect link for further information.
Lead

POSTED

1 day ago

DEADLINE

in 5 days
NAICS: 325412
New
Federal
Furosemide Tablets SolicitationThe solicitation is for the procurement of Furosemide tablets, issued by the Defense Logistics Agency (DLA) Troop Support, part of the Department of Defense. It is identified under solicitation number SPE2D2-26-R-0005 and was posted on April 21, 2026. The solicitation is in its presolicitation phase, with responses due by May 21, 2026, at 7:00 PM. The contract falls under the NAICS code 325412, which pertains to pharmaceutical manufacturing, and is managed by an office located in Philadelphia, Pennsylvania. No specific type of set-aside is indicated for this solicitation. The place of performance details are unspecified. Key points of contact for this solicitation include Nancy Fernandez and Jason C. Wray, both reachable via provided email addresses and phone numbers. Interested parties can access the full solicitation and related information through the provided online link on the SAM.gov website.
DLA Troop Support

POSTED

1 day ago

DEADLINE

in 21 days

AI Contract Overview

Show more

The Department of National Defence, through its Strategic Medical Countermeasures Program and on behalf of the Canadian Forces Health Services Group, is seeking to procure Pralidoxime. This medication is intended for treating Canadian Armed Forces members who may have been exposed to chemical warfare agents. The contract initially requires the delivery of 1,025 doses by March 31, 2026, with an option to order up to an additional 4,100 doses between April 1, 2026, and March 31, 2030. There are no special security requirements for this procurement. This solicitation is open exclusively to Canadian suppliers and those from applicable trading partners, consistent with the policy on reciprocal procurement. The Crown maintains the right to negotiate with suppliers throughout the procurement process. Interested parties must submit their offers by January 22, 2026. The contract is managed by the Department of National Defence, and the point of contact for this procurement is Stephen Brown. Offers may be submitted in either of Canada’s official languages, and the place of performance is Canada, with worldwide delivery expected.

General Info

Department of National Defence seeks Pralidoxime supply: 1,025 doses by 2026, optional 4,100 doses later.

Agency

Government of Canada → Department of National Defence

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

World, CAN

Set-Aside

NONE

Documents

(4)

Amendment 001 to Solicitation W6369-26-A033 Pralidoxime

PDF•2 pages•amendment

Amendment 001 to Solicitation W6369-26-A033 Pralidoxime

PDF•2 pages•amendment

RFP W6369-26-A033 Pralidoxime National Defence Canada

PDF•58 pages•rfp

RFP W6369-26-A033 Pralidoxime

PDF•55 pages•rfp

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of National Defence
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of National Defence
Office AddressN/A
Contacts
Stephen BrownContracting Authority
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 1,025 doses to be delivered before 31 March 2026. Optional requirements of 4,100 doses to be requested and delivered between 01 April 2026 and 31 March 2030. There are no security requirements associated with this requirement. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.